Incidence, risk of infection and survival of hairy cell Leukaemia in Denmark

Danish Medical Bulletin

Volumn 57, Issue 12, 2010, Pages

  Teodorescu, Manuela ^a   Engebjerg, Malene Cramer ^b   Johansen, Preben ^a   Nørgaard, Mette ^b   Gregersen, Henrik ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTEREMIA; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; CASE CONTROL STUDY; DENMARK; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; INFANT; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; PNEUMONIA; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 78650145203     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dores GM, Matsuno RK, Weisenburger DD et al. Hairy cell leukaemia: a heterogeneous disease? Br J Haematol 2008:142;45-51.
2. Morton LM, Wang SS, Devesa SS et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-276.
3. Paltiel O, Adler B, Barchana M et al. A population-based study of hairy cell leukemia in Israel. Eur J Haemat 2006:77:372-377.
4. Kristinsson SY, Vidarsson B, Agnarsson BA et al. Epidemiology of hairy cell leukemia in Iceland. Hematol J 2002;3:145-147.
5. Cartwright RA, Gilman EA, Gurney KA. Time trends in incidence of haematological malignancies and related conditions, Br J Haematol 1999:106:281-295.
6. Polliack A. Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders. Rev Clin Exp Hematol 2002;6:366-388.
7. th edition. Baltimore: Williams & Wilkins, 2003.
8. Saven A, Burian C, Koziol JA et al. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918-926.
9. Else M, Dearden CE, Matutes E et al. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733-740.
10. Jehn U, Bartl R, Dietzfelbinger H et al. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2- chlorodeoxyadenosine. Leukemia 2004;1476-1481.
11. Goodman GR, Burian C, Koziol JA et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891-896.
12. Flinn IW, Kopecky KJ, Foucar MK et al. Long-term follow-up of remission duration, mortality and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000;962 981-986.
13. Schirmer M, Hilbe W, Geisen F et al. T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine. Acta Haematol 1997;97:180-183.
14. Golomb HM, Hadad LJ. Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 1984;16:393-401.
15. Kraut EH. Clinical manifestations and infectious complications of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003;16:33-40.
16. Damaj G, Kuhnowski F, Marolleau JP et al. Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients. Eur J Haematol 2009;83:246-250.
17. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-2399.
18. Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review [Article in Danish]. Ugeskr Læger 2001;164: 33-37.
19. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
20. Dasanu CA, Ichim TE, Alexandrescu DT. Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. Expert Opin Drug Saf 2010;9:55-64.